Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the... Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the creation of innovative and high-quality medications that address significant medical needs across various therapeutic areas. The company is well-regarded for its diverse product portfolio, which includes treatments for cancer, cardiovascular diseases, and autoimmune conditions. Simcere is heavily invested in R&D, collaborating with global partners to advance translational medicine and bring cutting-edge therapies to market. Its commitment to scientific excellence and patient-centric solutions positions it at the forefront of the pharmaceutical industry. Headquartered in Nanjing, China, Simcere plays an influential role not only in the Chinese healthcare market but also has a growing presence in the international arena, contributing to the global effort of improving health outcomes through innovative drug development.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Simcere Pharmaceutical Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Simcere Pharmaceutical Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Simcere Pharmaceutical Group's data?

Start your 30-day free trial to request a data review for Simcere Pharmaceutical Group.

Start Free Trial

Legal Center Contact Us